CHI Yu-jia, ZHAO Jun, GAO Yu-er. Efficacy of Atezolizumab for First-Line Treatment of Metastatic Nonsquamous Non- Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 58-60. DOI: 10.12019/j.issn.1671-5144.2020.01.013
|
Citation:
|
CHI Yu-jia, ZHAO Jun, GAO Yu-er. Efficacy of Atezolizumab for First-Line Treatment of Metastatic Nonsquamous Non- Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 58-60. DOI: 10.12019/j.issn.1671-5144.2020.01.013
|
CHI Yu-jia, ZHAO Jun, GAO Yu-er. Efficacy of Atezolizumab for First-Line Treatment of Metastatic Nonsquamous Non- Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 58-60. DOI: 10.12019/j.issn.1671-5144.2020.01.013
|
Citation:
|
CHI Yu-jia, ZHAO Jun, GAO Yu-er. Efficacy of Atezolizumab for First-Line Treatment of Metastatic Nonsquamous Non- Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(1): 58-60. DOI: 10.12019/j.issn.1671-5144.2020.01.013
|
DownLoad: